Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1957 Nov;36(11):1546–1550. doi: 10.1172/JCI103551

The Potentiation of Exogenous Insulin by Tolbutamide in Depancreatized Dogs1

Raymond Caren a, Lucille Corbo a
PMCID: PMC1072758  PMID: 13475492

Full text

PDF
1546

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ANDERSON R. C., KIRTLEY W. R., RIDOLFO A. S., ROOT M. A. Clinical and pharmacological effects of substance BZ-55 in diabetes; (p-aminophenylsulfonyl butylcarbamide). Diabetes. 1956 Sep-Oct;5(5):351–357. doi: 10.2337/diab.5.5.351. [DOI] [PubMed] [Google Scholar]
  2. CAMPBELL J. The action of BZ-55 in dogs. II. Observations on depancreatized and metahypophyseal diabetic dogs. Can Med Assoc J. 1956 Jun 15;74(12):962–965. [PMC free article] [PubMed] [Google Scholar]
  3. CREUTZFELDT W., TECKLENBORG E. Synthalinhypoglykämie, A-Zellen und Glucagon. Klin Wochenschr. 1955 Jan 1;33(1-2):43–44. doi: 10.1007/BF01466926. [DOI] [PubMed] [Google Scholar]
  4. DOLGER H. Clinical experience with orinase. Metabolism. 1956 Nov;5(6 Pt 2):947–952. [PubMed] [Google Scholar]
  5. DUNCAN G. G., JOINER C. L., LEE C. T. Methods of selection of diabetic patients sensitive to sulfonylurea compounds. Metabolism. 1956 Nov;5(6 Pt 2):964–971. [PubMed] [Google Scholar]
  6. FERNER H., RUNGE W. Die Langerhansschen Inseln von Diabetikern nach Behandlung mit dem oralen Antidiabetikum BZ 55. Dtsch Med Wochenschr. 1956 Mar 9;81(10):331–333. doi: 10.1055/s-0028-1115690. [DOI] [PubMed] [Google Scholar]
  7. FRITZ I. B., LEVINE R., MORTON J. V., WEINSTEIN M. Studies on the mechanism of action of the sulfonylureas. Metabolism. 1956 Nov;5(6 Pt 2):744–748. [PubMed] [Google Scholar]
  8. GILBERTSEN A. S., GOETZ F. C., JOSEPHSON V. Acute effects of orinase on peripheral glucose utilization. Metabolism. 1956 Nov;5(6 Pt 2):788–800. [PubMed] [Google Scholar]
  9. LOUBATIERES A. L'utilisation de certaines substances sulfamidées dans le traitement du diabète sucré expérimental; recherches personnelles (1942-1946). Presse Med. 1955 Dec 10;63(82):1701–1703. [PubMed] [Google Scholar]
  10. MIRSKY I. A., PERISUTTI G., DIENGOTT D. The inhibition of insulinase by hypoglycemic sulfonamides. Metabolism. 1956 Mar;5(2):156–161. [PubMed] [Google Scholar]
  11. MIRSKY I. A., PERISUTTI G., JINKS R. Ineffectiveness of sulfonylureas in alloxan diabetic rats. Proc Soc Exp Biol Med. 1956 Mar;91(3):475–477. doi: 10.3181/00379727-91-22297. [DOI] [PubMed] [Google Scholar]
  12. SIREK A., SIREK O. V. The action of BZ-55 in dogs. I. Observations on depancreatized and Houssay dogs. Can Med Assoc J. 1956 Jun 15;74(12):960–962. [PMC free article] [PubMed] [Google Scholar]
  13. TYBERGHEIN J. M., HALSEY Y. D., WILLIAMS R. H. Action of butyltolylsulfonylurea on liver glycogenolysis. Proc Soc Exp Biol Med. 1956 Jun;92(2):322–324. doi: 10.3181/00379727-92-22465. [DOI] [PubMed] [Google Scholar]
  14. VAUGHAN M. In vitro studies on the action of sulfonamide hypoglycemic agents. Science. 1956 May 18;123(3203):885–886. doi: 10.1126/science.123.3203.885. [DOI] [PubMed] [Google Scholar]
  15. VON HOLT C., VON HOLT L., KRONER B., KUHNAU J. Chemische Ausschaltung der A-Zellen der Langerhansschen Inseln. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1955;224(1):66–77. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES